We are live on ! Find out more
CEL

Cellcom Israel, Ltd.
CEL

Delisted

CEL was delisted on the 8th of February, 2021.

35 hedge funds and large institutions have $45.9M invested in Cellcom Israel, Ltd. in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less capital invested

Capital invested by funds: $49.6M → $45.9M (-$3.66M)

15% less funds holding

Funds holding: 4135 (-6)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
7
Reduced
9
Closed
7
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
+$23K

CEL Hedge Fund Activity: Q1 2019 in Review

35 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Cellcom Israel, Ltd. (CEL) for Q1 2019, worth a combined $45.9M — down 7.4% from $49.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CEL and 1 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 7 added.

The largest buyer was Arrowstreet Capital, adding an estimated $1.2M. The largest seller was Meitav Investment House, cutting an estimated $360K.

  • 35 institutional investors held Cellcom Israel, Ltd. (CEL) as of Q1 2019, down from 41 in Q4 2018.
  • Funds reported $45.9M of Cellcom Israel, Ltd. stock for Q1 2019, down 7.4% quarter-over-quarter.
  • 1 fund opened new Cellcom Israel, Ltd. positions in Q1 2019 and 7 closed out, a net change of -6 holders.
  • The largest Cellcom Israel, Ltd. buyer in Q1 2019 was Arrowstreet Capital, an estimated $1.2M added.
  • The largest Cellcom Israel, Ltd. seller in Q1 2019 was Meitav Investment House, an estimated $360K sold.

Based on aggregated 13F filings for Q1 2019.